GLP-1R, a core member of the GPCR family, is widely present on the surfaces of various cells in the human body.1,2 By specifically binding to the key hormone GLP-1, it regulates blood glucose levels and lipid metabolism.3,4 This receptor and its agonists hold significant therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases .5,6,7 GLP-1 is a peptide produced by the cleavage of proglucagon, mainly synthesized in the intestinal mucosal L-cells, pancreatic islet -cells, and neurons in the nucleus of the solitary tract.3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression.8,9,10 These mechanisms make GLP-1RAs powerful tools for controlling blood glucose and improving metabolic syndrome
McDonald says
:BIYG5349 : : V : 5 : () : : : : 1-2 V :2 :2 5 1500
Effervescents work similarly, and have the added advantage of flavour
If that proves to be the case, doctors might someday optimize patients GLP-1 regimens for long-term cardiovascular benefits, not just for diabetes management and weight loss, researchers said in a report published online ahead of peer review
This would not reduce your risk and might increase it
:format(webp))
(mh=R0vorxasCcQg2lI6)2.jpg)
